Positive predictive value of ERBB2 copy number gain by tissue or circulating tumor DNA next-generation sequencing across advanced cancers

Background: The correlation of ERBB2 copy number gain (CNG) from tissue or circulating tumor DNA (ctDNA) by next-generation sequencing (NGS) with standard HER2 tissue evaluation is not well understood. Materials and Methods: We retrospectively identified patients with ERBB2 CNG on commercial NGS. We...

Descripción completa

Detalles Bibliográficos
Autores principales: Shah, Ami N., Sunderraj, Ashwin, Finkelman, Brian, See, Sharlene H., Davis, Andrew A., Gerratana, Lorenzo, Wehbe, Firas, Katam, Neelima, Mahalingam, Deva, Gradishar, William J., Behdad, Amir, Blanco, Luis, Cristofanilli, Massimo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2022
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8809397/
https://www.ncbi.nlm.nih.gov/pubmed/35126865
http://dx.doi.org/10.18632/oncotarget.28188

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8809397/
https://www.ncbi.nlm.nih.gov/pubmed/35126865
http://dx.doi.org/10.18632/oncotarget.28188

Ejemplares similares